Decreased Cardiotoxicity With Infusional Doxorubicin
Oct 21, 2021•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We return to our Landmarks of OncoPharm series to dive deep into an article that provided some of our foundational understanding of how anthracycline cardiotoxicity risk is influenced by rate of administration.
Link: https://pubmed.ncbi.nlm.nih.gov/2910423/
For the best experience, listen in Metacast app for iOS or Android